Ashland completes second expansion of bioresorbable polymers manufacturing and R&D lab in Ireland

Planned ribbon cutting event demonstrates company commitment to investment in innovation platforms and local presence

15-Aug-2024

Symbolic image

Computer-generated image

Ashland has completed the second expansion of its pharmaceutical injectables manufacturing and R&D lab at the National Science Park in Mullingar, Ireland and will celebrate the moment with a ribbon-cutting ceremony on August 22, 2024.

This enhancement, completed as scheduled, significantly expands Ashland’s footprint, capabilities and headcount of their Irish facility focused on delivery of innovative bioresorbable polymer chemistry to meet increasing market demand. Continuing investment also underscores Ashland’s commitment to the company’s new innovative technology platforms announced last September. One of seven platforms, bioresorbable polymers enable customers to create improved pharmaceuticals, medical devices and tissue engineering solutions.

This project is supported by the Irish Government through IDA Ireland.

“It is excellent news that Ashland has completed their expansion project on their manufacturing and R&D lab at the National Science Park in Mullingar,” said Peter Burke, minister for enterprise trade and employment, Ireland. “This significant investment in my hometown and in the Midlands region itself demonstrates Ashland’s commitment to Ireland and further strengthens Ireland as a global leader in the life sciences sector. It is encouraging to know that the work undertaken there will lead to innovative medical solutions. As Ashland expands, they will find ample talented graduates in the local surrounds and from the nearby Technological University of the Shannon (TUS) to fulfil that growth. All the best to the Ashland team on this momentous occasion.”

https://www.chemeurope.com/en/news/1184188/ashland-completes-second-expansion-of-bioresorbable-polymers-manufacturing-and-r-d-lab-in-ireland.html